Alina Ferster
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL.
Journal: Pediatric blood & cancer
Published: June 01, 2026
Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 08, 2026
Fibroblast-based radiosensitivity assays as a clinically valuable tool for (severe) combined immunodeficiency syndromes.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: October 24, 2024
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments.
Journal: Pediatric blood & cancer
Published: July 24, 2024
Long-term neurotoxicity among childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC Children Leukemia Group studies.
Journal: Discover oncology
Published: August 31, 2023
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.
Journal: The New England journal of medicine
Published: April 26, 2023
Spermatogenesis after gonadotoxic childhood treatment: follow-up of 12 patients.
Journal: Human reproduction open
Published: March 14, 2023
The prognostic value of IKZF1plus in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial.
Journal: Pediatric blood & cancer
Published: December 06, 2022
Somatic genetic alterations predict hematological progression in GATA2 deficiency.
Journal: Haematologica
Published: October 13, 2022
Last Updated: 09/26/2026